Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
4,920 Amgen Inc. $AMGN Shares Bought by VIRGINIA RETIREMENT SYSTEMS ET Al
Amgen Inc. $AMGN Stock Acquired by International Assets Investment Management LLC - Stock Observer
Amgen (AMGN) Gets A Fresh Look As Phase 3 Wins Meet A Pricey Narrative
New CFO Appointment Could Be A Big Moment For Mattel (MAT)
Amgen (AMGN) Stock Could Trade At A Discount To Cash Flow
Top Biotech Stocks To Follow Today - October 29th - Stock Observer
Clinics: Biontech, Genmab ADCs hit PFS for breast, ovarian cancer
How to Build $6,800 a Month in Dividend Income Without Selling a Single Share
What SPDR Dow Jones Industrial Avg ETF (DIA) Sold: Goldman Leads on Oct. 28
Amgen Inc. $AMGN Shares Acquired by VestGen Advisors LLC
United Asset Strategies Inc. Sells 1,385 Shares of Amgen Inc. $AMGN - Daily Political
2,578 Amgen Inc. $AMGN Shares Acquired by Soltis Investment Advisors LLC - Daily Political
3 Dividend Stocks With Yields Over 2%
Neuroendocrine Prostate Cancer Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | ABNewswire
What SPDR Dow Jones Industrial Avg ETF (DIA) Sold: Goldman Leads on Oct. 27
Amgen Braces for Rising Expenses Ahead of Q3 Results-Is a Profit Squeeze Looming?
Amgen Inc. $AMGN Stock Sold by D.A. Davidson & CO.
Amgen Inc. $AMGN Stock Holdings Reduced by Conning Inc.
Amgen Inc. $AMGN Shares Sold by Bokf Na
AMGEN ANNOUNCES WEBCAST OF 2026 THIRD QUARTER FINANCIAL RESULTS | Morningstar
What Could Amgen (AMGN) Rare Disease Updates Mean For Its Growth Story?
Amgen (NASDAQ:AMGN) Reaches New 1-Year High Following Dividend Announcement
Regeneron and Amgen call a truce on two Eylea biosimilar patents
Vertex Pharmaceuticals Incorporated $VRTX Stock Position Boosted by Sigma Planning Corp
Amgen (AMGN) Posts Positive Phase 3 Sjögren's Data As Autoimmune Readout Broadens - Simply Wall St News
Regeneron, Amgen Further Narrow Lawsuit Over Eylea Biosimilars
FDA warns Amgen over cancer drug promotional video
Biotech Stocks To Watch Now - October 27th - Markets Daily
Amgen (AMGN) Projected to Announce Earnings on Tuesday
State Street SPDR Dow Jones (DIA) Sells Goldman Sachs and Caterpillar on Oct. 23
WealthCare Asset Management LLC Sells 1,268 Shares of Amgen Inc. $AMGN - Daily Political
Gilead Sciences (GILD) Expected to Post Earnings on Thursday - Daily Political
Does Amgen (AMGN) Have Enough Cash Flow To Justify Its Price?
Amgen names David Gibbs to board of directors
AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORS | Morningstar
Best Biotech Stocks Worth Watching - October 26th - Markets Daily
ESMO '26: A cancer vaccine debate, Roche's KRAS progress and Amgen's 'unprecedented' data
4,797 Amgen Inc. $AMGN Shares Purchased by Sigma Planning Corp - Zolmax
Amgen Inc. $AMGN Stock Position Raised by Sigma Planning Corp
2,418 Shares of Amgen Inc. $AMGN Bought by IRON Financial LLC
Roche Drug Beats Amgen, Bristol Rivals in Lung Cancer Study (1)
Barclays Reaffirms Their Buy Rating on Merck & Company (MRK)
Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), Ascendis Pharma (ASND) and Amgen (AMGN)
Amgen announces Phase 3 results of Imdelltra with AstraZeneca's Imfinzi
AstraZeneca announces results from DeLLphi-305 trial of IMFINZI
Teva (TEVA) Gets a Buy from Piper Sandler
1,429 Amgen Inc. $AMGN Shares Sold by Citizens Financial Group Inc. RI - Markets Daily
Amgen Inc. $AMGN Stake Lessened by Atlas Private Wealth Advisors
Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study
New Amgen drug combination shows survival gains in lung cancer trial
Amgen-AstraZeneca drug combination cut risk of death in small cell lung cancer by 58%
Sterling Capital Management LLC Purchases 22,485 Shares of Amgen Inc. $AMGN
Amgen Reports Combo Cuts Lung Cancer Death Risk 58%
NBT Bank N.A. Acquires New Shares in Amgen Inc. $AMGN
Vision Financial Markets LLC Makes New Investment in Amgen Inc. $AMGN - Stock Observer
AbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's?
Forget Chasing 7% Yields: These 5 Dividend Stocks Offer Something Different
14,670 Amgen Inc. $AMGN Shares Sold by Investment House LLC
Amgen Inc. $AMGN Shares Purchased by Brookstone Capital Management
Amgen Inc. $AMGN Shares Sold by Axxcess Wealth Management LLC
Amgen Inc. (NASDAQ:AMGN) Stock Has Consensus Price Target of $387.93 According to Analysts - Stock Observer
Amgen Inc. $AMGN Shares Sold by Investment House LLC - Daily Political
Bispecific dual T cell agonist invikafusp alfa in solid tumors: the phase 1/2 START-001 trial
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial
Amgen (NASDAQ:AMGN) Sets New 1-Year High - Should You Buy? - Markets Daily
Amgen (NASDAQ:AMGN) Sets New 1-Year High - Should You Buy?
Amgen Inc. $AMGN Shares Sold by Foster Victor Wealth Advisors LLC
35,730 Amgen Inc. $AMGN Shares Acquired by Crossmark Global Holdings Inc.
Latin America's Quiet Rise: Argentina and Brazil Enter the Biosimilars Market Spotlight
Multiple myeloma in the Netherlands: 35-year trends in incidence and survival
Amgen (AMGN) Sales Grew 10%, but Can Earnings Catch Up to the Price?
Sawyer & Company Inc Makes New Investment in Amgen Inc. $AMGN
State Street SPDR Dow Jones (DIA) Sells Goldman Sachs and Caterpillar on Monday
Amgen Inc. $AMGN Stock Holdings Raised by Robeco Institutional Asset Management B.V.
Nisa Investment Advisors LLC Purchases 8,294 Shares of Amgen Inc. $AMGN
Biotech Stocks To Keep An Eye On - October 18th - Stock Observer
AstraZeneca and Amgen's Tezspire Achieves 69% Remission in Eosinophilic Esophagitis Trial, ETPharma
2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going)
Dow leads Wall Street higher, investors focus on healthcare stocks
Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors
Eli Lilly Rises 4% While Foundayo Nears European Approval; Amgen and Novo Nordisk Edge Higher
AstraZeneca & Amgen's Tezspire Meets Phase 3 Endpoints In Eosinophilic Esophagitis
AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial
Amgen Inc. $AMGN Stock Bought by Sumitomo Mitsui DS Asset Management Company Ltd
TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS
Wall Street Zen Upgrades Amgen (NASDAQ:AMGN) to Buy - Markets Daily
10,773 Amgen Inc. $AMGN Shares Sold by Novem Group
5,750 Shares of Amgen Inc. $AMGN Bought by Greg Jennings LLC - Markets Daily
Merck vs. Amgen: Which Dividend Stock Pays You More in 10 Years?
Greg Jennings LLC Buys New Position in Amgen Inc. $AMGN - Stock Observer
Amgen Has the Drugs and the Dividend. Now It Needs the Growth
Amgen News
Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?
CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?
Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?
Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks
Latest news
Show more
Amazon Q3 Earnings: AWS Growth Hits 39.3% as AI Spending Weighs on Cash Flow
Intel Stock Crashes 18% as Weak Q4 Forecast Overshadows 78% AI Server Growth
Bitcoin Price Falls Below $80,000 as Binance Reports $6.3 Billion Security Incident
Alphabet Stock Falls 12% as Search Slowdown and AI Spending Unsettle Investors
Apple Earnings Preview: Can iPhone Growth and the Duo Foldable Justify AAPL’s Valuation?
